---
title: Vision-Saving Diabetic Retinopathy Screening Device for Your Primary Care Practice
description: Arm your primary care practice with a simple and affordable screening system that enables retinal assessment, in order to help preventable blindness.
image: https://blog.cmecorp.com/hubfs/Vision-Saving%20Diabetic%20Retinopathy%20Screening%20Device%20for%20Your%20Primary%20Care%20Practice.jpg
---

- Welcome!
- [Sign In](https://www.cmecorp.com/customer/account/login/referer/aHR0cHM6Ly93d3cuY21lY29ycC5jb20v/)
- or
- [Create an Account](https://www.cmecorp.com/customer/account/create/)
- [![](https://www.cmecorp.com/media/public/icons8-phone-50.png) 800.338.2372](tel:8003382372)

[![CME Corp](https://blog.cmecorp.com/hs-fs/hubfs/CME_CORP_LOGO_FIN_2018_PMS_300dpi-1.png?width=1331&height=442&name=CME_CORP_LOGO_FIN_2018_PMS_300dpi-1.png "CME Corp")](http://www.cmecorp.com)

[Find My Account Manager](https://www.cmecorp.com/about/contact-us.html) | [Contact Us](https://www.cmecorp.com/about/contact-us.html)

Search:

![](https://blog.cmecorp.com/hubfs/_images/search-icon.jpg)

[![](https://blog.cmecorp.com/hs-fs/hubfs/_images/mini-cart.jpg?width=23&height=21&name=mini-cart.jpg)](http://www.cmecorp.com/checkout/cart/)

- [CME Expertise](https://www.cmecorp.com/cme-expertise.html) 
    - [Hospitals / IDNs](https://www.cmecorp.com/cme-expertise/hospitals.html)
    - [Laboratory](https://www.cmecorp.com/cme-expertise/laboratory.html)
    - [Imaging](https://www.cmecorp.com/cme-expertise/imaging.html)
    - [Surgery Centers](https://www.cmecorp.com/cme-expertise/surgery-centers.html)
    - [Clinics](https://www.cmecorp.com/cme-expertise/clinics.html)
    - [Physician Offices](https://www.cmecorp.com/cme-expertise/physician-offices.html)
    - [Behavioral Health Facilities](https://www.cmecorp.com/cme-expertise/behavioral-health.html)
    - [Long Term Care](https://www.cmecorp.com/cme-expertise/long-term-care.html)
    - [Rehabilitation Centers](https://www.cmecorp.com/cme-expertise/rehabilitation.html)
    - [Government Services](https://www.cmecorp.com/cme-expertise/government.html)
    - [Emergency Medical Services](https://www.cmecorp.com/cme-expertise/emergency-medical-services.html)
- [Integrated Services](https://www.cmecorp.com/integrated-services.html) 
    - [CAD-Based Layout & Design](https://www.cmecorp.com/integrated-services/cad-based-layout-and-design.html)
    - [Project Management](https://www.cmecorp.com/integrated-services/project-management.html)
    - [Direct-to-Site Services](https://www.cmecorp.com/integrated-services/direct-to-site-services.html)
    - [Biomedical Services & Technical Solutions](https://www.cmecorp.com/integrated-services/biomedical-services.html)
    - [Contractor Specialties](https://www.cmecorp.com/integrated-services/contractor-specialties.html)
- [Find Products](https://www.cmecorp.com/shop.html) 
    - [Shop By Category](https://www.cmecorp.com/new-shop/shop-by-category.html)
    - [Shop By Manufacturer](https://www.cmecorp.com/new-shop/brands.html)
    - [Digital Solutions Guide](https://cmesolutionsguide.com/)

# Vision-Saving Diabetic Retinopathy Screening Device for Your Primary Care Practice

[![Vision-Saving Diabetic Retinopathy Screening Device for Your Primary Care Practice](https://blog.cmecorp.com/hubfs/Vision-Saving%20Diabetic%20Retinopathy%20Screening%20Device%20for%20Your%20Primary%20Care%20Practice.jpg)](https://blog.cmecorp.com/vision-saving-diabetic-retinopathy-screening-device-for-your-primary-care-practice)

By [CME Corp Staff](https://blog.cmecorp.com/author/cme-corp-staff) | June 17, 2016

- [Tweet](https://twitter.com/share)

Diabetic retinopathy is the [leading cause of blindness among working-age adults](http://www.cdc.gov/visionhealth/basics/ced/index.html).  According to the 7th edition of the Diabetes Atlas, more than [400 million people globally currently live with diabetes](http://www.diabetesatlas.org/) and by 2040 the number will grow to 642 million.  

It is estimated by the American Academy of Ophthalmology that [80% of diabetics will eventually develop some level of diabetic retinopathy](http://www.aao.org/preferred-practice-pattern/diabetic-retinopathy-ppp-updated-2016).  Despite the fact that early detection and treatment [can prevent up to 95% of vision loss cases](https://nei.nih.gov/health/diabetic/retinopathy), typically only half of patients with diabetes see an eye specialist for an annual retinal exam.1

These numbers should alarm anyone treating patients living with diabetes.  One of the best opportunities to help eradicate this leading cause of preventable blindness is to arm primary healthcare providers with a simple and affordable screening system that enables retinal assessment during a patient’s routine office visit.

**The Current Standard of Care**

The current standard of care for a patient with diabetes is to have a dilated retinal examination by a qualified eye specialist, usually on an annual basis.  This standard would be adequate if every person living with diabetes complied with their annual referral to visit the eye specialist—but only half do so.

**A New Standard of Care**

More than a decade ago, the American Academy of Ophthalmology indicated that single-field fundus imaging—used in most teleretinal screening solutions—can successfully screen for diabetic retinopathy and detect those patients with disease for referral to eye specialists for ophthalmologic evaluation and management.2

While teleretinal imaging technology is not new and has been proven successful, there have been significant barriers to widespread adoption of this technology in primary care settings, mainly:

- cost
- device size
- absence of easily accessible diagnostic interpretation services by a nationwide network of board-certified retinal specialists.

**These barriers have now been breached by an innovative new device, the [RetinaVue™ 100 Imager](https://www.cmecorp.com/welch-allyn-rv100-b-retinavue-network.html).  This new device does so in the following ways:**

1. The new handheld RetinaVue™ 100 Imager makes retinal assessment in primary care settings truly practical by shattering the price barrier at two-thirds less than desktop fundus cameras!
2. The RetinaVue™ 100 Imager is also very easy to operate.  With minimal training, any healthcare professional in the office can capture and transmit high-quality fundus images over the RetinaVue™ Network.  Critical features include touchless image capture and autofocus technologies, as well as integrated image quality assessment software.
3. In addition to a design that allows easy and fast image capture, RetinaVue™ P.C.’s national network of fellowship-trained, board-certified retinal specialists will return a complete diagnostic report and referral/screening plan the same day.

> *“What makes this camera different from everything else on the market is its compact size, low price, and ease of use,”* said Dr. Chaum, M.D., Ph.D., Chief Medical Officer, RetinaVue™ P.C.  *“The RetinaVue 100 Imager provides primary care providers with the opportunity to evaluate patients simply, quickly and cost-effectively.  This revolutionary camera is the key to making a very significant impact on reducing vision loss and preventing blindness from diabetes.”*

**Benefits of Diabetic Retinal Assessment in Primary Care Settings**

Screening for diabetic retinopathy in primary care settings enables more efficient management of patients with diabetes and, according to an article by Mansberger et al, in Telemedicine and e-Health, can increase compliance with the diabetic retinal exam (DRE) up to 90% within one-year.3  This goes a long way in helping ensure that vision-threatening diabetic retinopathy is detected early enough to prevent blindness and improve DRE quality metrics for the practice.

Annual retinal examinations are included in the NCQA HEDIS ratings program, the Medicare Advantage “Stars” quality rating program and Medicare quality rating programs.  By intercepting patients during routine primary care office visits, healthcare providers can potentially qualify for financial incentives under these programs.  In fact, four of the top five commercial healthcare plans provide coverage for RetinaVue™ diagnostic reports in primary care settings. Many healthcare providers enjoy a favorable return on investment within their first year. DRE coding options include CPT codes 92250, 92227 and 92228.  Consult your payer partners to understand coding and coverage options.

The [RetinaVue™ 100](https://www.welchallyn.com/content/dam/welchallyn/documents/upload-docs/Product-Literature/Brochure/SM4144RevC_RVNetworkBrochure_WR.pdf) Imager is also non-mydriatic for increased patient comfort.  Patients can enjoy the comfort and convenience of getting their diabetic retinal exam as part of a regularly scheduled visit without the hassle of eye dilation, saving the time, inconvenience, and cost associated with a separate specialist visit.

[CME](https://www.cmecorp.com/?utm_source=hubspot&utm_medium=blog&utm_campaign=cme%20insiders) is proud to partner with [Welch Allyn](https://www.cmecorp.com/brands/welch-allyn?utm_source=hubspot&utm_medium=blog&utm_campaign=cme%20insiders) in making this innovative product available to our customers.  To learn more about how your practice can simply and affordably screen for diabetic retinopathy, [visit our website](http://www.cmecorp.com) or call us at 800.338.2372 to talk to one of our medical equipment specialists.

---

**About CME:** CME Corp is the nation’s premier source for [healthcare equipment](https://www.cmecorp.com/solutions/capital-equipment.html?utm_source=hubspot&utm_medium=blog&utm_campaign=cme%20insiders), [turnkey logistics](https://www.cmecorp.com/solutions/direct-to-site-services.html?utm_source=hubspot&utm_medium=blog&utm_campaign=cme%20insiders), and [biomedical services](https://www.cmecorp.com/solutions/biomedical-services.html?utm_source=hubspot&utm_medium=blog&utm_campaign=cme%20insiders), representing 2 million+ products from more than 2,000 manufacturers.

With two corporate offices and 35+ service centers, our mission is to help [healthcare facilities](https://www.cmecorp.com/who-we-serve.html?utm_source=hubspot&utm_medium=blog&utm_campaign=cme%20insiders) nationwide reduce the cost of the equipment they purchase, make their equipment specification, delivery, installation, and maintenance processes more efficient, and help them seamlessly launch, renovate and expand on schedule.

[Capital Medical Equipment](https://blog.cmecorp.com/topic/capital-medical-equipment)

![](https://blog.cmecorp.com/hs-fs/hubfs/logo.png?height=100&name=logo.png)

Written by   
[CME Corp Staff](https://blog.cmecorp.com/author/cme-corp-staff)   
 CME Corp's staff explores and presents the latest findings, news, and trends of the healthcare industry.

### Posts by Tag

- [June 2017 (14)](https://blog.cmecorp.com/archive/2017/06)
- [October 2017 (8)](https://blog.cmecorp.com/archive/2017/10)
- [September 2023 (8)](https://blog.cmecorp.com/archive/2023/09)
- [November 2015 (7)](https://blog.cmecorp.com/archive/2015/11)
- [December 2015 (7)](https://blog.cmecorp.com/archive/2015/12)
- [July 2017 (7)](https://blog.cmecorp.com/archive/2017/07)
- [September 2017 (7)](https://blog.cmecorp.com/archive/2017/09)
- [November 2017 (7)](https://blog.cmecorp.com/archive/2017/11)
- [October 2023 (7)](https://blog.cmecorp.com/archive/2023/10)
- [August 2014 (6)](https://blog.cmecorp.com/archive/2014/08)
- [June 2016 (6)](https://blog.cmecorp.com/archive/2016/06)
- [February 2018 (6)](https://blog.cmecorp.com/archive/2018/02)
- [April 2018 (6)](https://blog.cmecorp.com/archive/2018/04)
- [May 2018 (6)](https://blog.cmecorp.com/archive/2018/05)
- [August 2025 (6)](https://blog.cmecorp.com/archive/2025/08)
- [July 2014 (5)](https://blog.cmecorp.com/archive/2014/07)
- [September 2014 (5)](https://blog.cmecorp.com/archive/2014/09)
- [January 2017 (5)](https://blog.cmecorp.com/archive/2017/01)
- [December 2017 (5)](https://blog.cmecorp.com/archive/2017/12)
- [November 2021 (5)](https://blog.cmecorp.com/archive/2021/11)
- [June 2023 (5)](https://blog.cmecorp.com/archive/2023/06)
- [August 2023 (5)](https://blog.cmecorp.com/archive/2023/08)
- [November 2023 (5)](https://blog.cmecorp.com/archive/2023/11)
- [January 2024 (5)](https://blog.cmecorp.com/archive/2024/01)
- [April 2024 (5)](https://blog.cmecorp.com/archive/2024/04)
- [August 2024 (5)](https://blog.cmecorp.com/archive/2024/08)
- [October 2024 (5)](https://blog.cmecorp.com/archive/2024/10)
- [January 2025 (5)](https://blog.cmecorp.com/archive/2025/01)
- [April 2025 (5)](https://blog.cmecorp.com/archive/2025/04)
- [May 2025 (5)](https://blog.cmecorp.com/archive/2025/05)
- [July 2025 (5)](https://blog.cmecorp.com/archive/2025/07)
- [September 2025 (5)](https://blog.cmecorp.com/archive/2025/09)
- [April 2026 (5)](https://blog.cmecorp.com/archive/2026/04)
- [June 2026 (5)](https://blog.cmecorp.com/archive/2026/06)
- [June 2014 (4)](https://blog.cmecorp.com/archive/2014/06)
- [December 2014 (4)](https://blog.cmecorp.com/archive/2014/12)
- [April 2015 (4)](https://blog.cmecorp.com/archive/2015/04)
- [May 2016 (4)](https://blog.cmecorp.com/archive/2016/05)
- [December 2016 (4)](https://blog.cmecorp.com/archive/2016/12)
- [February 2017 (4)](https://blog.cmecorp.com/archive/2017/02)
- [May 2020 (4)](https://blog.cmecorp.com/archive/2020/05)
- [March 2021 (4)](https://blog.cmecorp.com/archive/2021/03)
- [April 2021 (4)](https://blog.cmecorp.com/archive/2021/04)
- [May 2021 (4)](https://blog.cmecorp.com/archive/2021/05)
- [September 2021 (4)](https://blog.cmecorp.com/archive/2021/09)
- [August 2022 (4)](https://blog.cmecorp.com/archive/2022/08)
- [April 2023 (4)](https://blog.cmecorp.com/archive/2023/04)
- [May 2023 (4)](https://blog.cmecorp.com/archive/2023/05)
- [July 2023 (4)](https://blog.cmecorp.com/archive/2023/07)
- [December 2023 (4)](https://blog.cmecorp.com/archive/2023/12)
- [February 2024 (4)](https://blog.cmecorp.com/archive/2024/02)
- [March 2024 (4)](https://blog.cmecorp.com/archive/2024/03)
- [May 2024 (4)](https://blog.cmecorp.com/archive/2024/05)
- [June 2024 (4)](https://blog.cmecorp.com/archive/2024/06)
- [July 2024 (4)](https://blog.cmecorp.com/archive/2024/07)
- [September 2024 (4)](https://blog.cmecorp.com/archive/2024/09)
- [December 2024 (4)](https://blog.cmecorp.com/archive/2024/12)
- [February 2025 (4)](https://blog.cmecorp.com/archive/2025/02)
- [March 2025 (4)](https://blog.cmecorp.com/archive/2025/03)
- [June 2025 (4)](https://blog.cmecorp.com/archive/2025/06)
- [October 2025 (4)](https://blog.cmecorp.com/archive/2025/10)
- [November 2025 (4)](https://blog.cmecorp.com/archive/2025/11)
- [December 2025 (4)](https://blog.cmecorp.com/archive/2025/12)
- [January 2026 (4)](https://blog.cmecorp.com/archive/2026/01)
- [February 2026 (4)](https://blog.cmecorp.com/archive/2026/02)
- [March 2026 (4)](https://blog.cmecorp.com/archive/2026/03)
- [May 2026 (4)](https://blog.cmecorp.com/archive/2026/05)
- [March 2014 (3)](https://blog.cmecorp.com/archive/2014/03)
- [April 2014 (3)](https://blog.cmecorp.com/archive/2014/04)
- [May 2014 (3)](https://blog.cmecorp.com/archive/2014/05)
- [May 2015 (3)](https://blog.cmecorp.com/archive/2015/05)
- [September 2015 (3)](https://blog.cmecorp.com/archive/2015/09)
- [October 2015 (3)](https://blog.cmecorp.com/archive/2015/10)
- [January 2016 (3)](https://blog.cmecorp.com/archive/2016/01)
- [April 2017 (3)](https://blog.cmecorp.com/archive/2017/04)
- [January 2018 (3)](https://blog.cmecorp.com/archive/2018/01)
- [July 2018 (3)](https://blog.cmecorp.com/archive/2018/07)
- [March 2019 (3)](https://blog.cmecorp.com/archive/2019/03)
- [June 2019 (3)](https://blog.cmecorp.com/archive/2019/06)
- [March 2020 (3)](https://blog.cmecorp.com/archive/2020/03)
- [June 2021 (3)](https://blog.cmecorp.com/archive/2021/06)
- [July 2021 (3)](https://blog.cmecorp.com/archive/2021/07)
- [March 2022 (3)](https://blog.cmecorp.com/archive/2022/03)
- [May 2022 (3)](https://blog.cmecorp.com/archive/2022/05)
- [June 2022 (3)](https://blog.cmecorp.com/archive/2022/06)
- [September 2022 (3)](https://blog.cmecorp.com/archive/2022/09)
- [November 2022 (3)](https://blog.cmecorp.com/archive/2022/11)
- [February 2023 (3)](https://blog.cmecorp.com/archive/2023/02)
- [November 2024 (3)](https://blog.cmecorp.com/archive/2024/11)
- [October 2014 (2)](https://blog.cmecorp.com/archive/2014/10)
- [January 2015 (2)](https://blog.cmecorp.com/archive/2015/01)
- [July 2015 (2)](https://blog.cmecorp.com/archive/2015/07)
- [August 2015 (2)](https://blog.cmecorp.com/archive/2015/08)
- [February 2016 (2)](https://blog.cmecorp.com/archive/2016/02)
- [March 2016 (2)](https://blog.cmecorp.com/archive/2016/03)
- [November 2016 (2)](https://blog.cmecorp.com/archive/2016/11)
- [May 2017 (2)](https://blog.cmecorp.com/archive/2017/05)
- [August 2017 (2)](https://blog.cmecorp.com/archive/2017/08)
- [March 2018 (2)](https://blog.cmecorp.com/archive/2018/03)
- [July 2019 (2)](https://blog.cmecorp.com/archive/2019/07)
- [January 2020 (2)](https://blog.cmecorp.com/archive/2020/01)
- [February 2020 (2)](https://blog.cmecorp.com/archive/2020/02)
- [August 2020 (2)](https://blog.cmecorp.com/archive/2020/08)
- [September 2020 (2)](https://blog.cmecorp.com/archive/2020/09)
- [October 2020 (2)](https://blog.cmecorp.com/archive/2020/10)
- [February 2021 (2)](https://blog.cmecorp.com/archive/2021/02)
- [August 2021 (2)](https://blog.cmecorp.com/archive/2021/08)
- [October 2021 (2)](https://blog.cmecorp.com/archive/2021/10)
- [January 2022 (2)](https://blog.cmecorp.com/archive/2022/01)
- [April 2022 (2)](https://blog.cmecorp.com/archive/2022/04)
- [January 2023 (2)](https://blog.cmecorp.com/archive/2023/01)
- [March 2023 (2)](https://blog.cmecorp.com/archive/2023/03)
- [November 2014 (1)](https://blog.cmecorp.com/archive/2014/11)
- [February 2015 (1)](https://blog.cmecorp.com/archive/2015/02)
- [March 2015 (1)](https://blog.cmecorp.com/archive/2015/03)
- [April 2016 (1)](https://blog.cmecorp.com/archive/2016/04)
- [July 2016 (1)](https://blog.cmecorp.com/archive/2016/07)
- [August 2016 (1)](https://blog.cmecorp.com/archive/2016/08)
- [September 2016 (1)](https://blog.cmecorp.com/archive/2016/09)
- [March 2017 (1)](https://blog.cmecorp.com/archive/2017/03)
- [August 2018 (1)](https://blog.cmecorp.com/archive/2018/08)
- [September 2018 (1)](https://blog.cmecorp.com/archive/2018/09)
- [October 2018 (1)](https://blog.cmecorp.com/archive/2018/10)
- [January 2019 (1)](https://blog.cmecorp.com/archive/2019/01)
- [April 2019 (1)](https://blog.cmecorp.com/archive/2019/04)
- [April 2020 (1)](https://blog.cmecorp.com/archive/2020/04)
- [June 2020 (1)](https://blog.cmecorp.com/archive/2020/06)
- [July 2020 (1)](https://blog.cmecorp.com/archive/2020/07)
- [November 2020 (1)](https://blog.cmecorp.com/archive/2020/11)
- [December 2020 (1)](https://blog.cmecorp.com/archive/2020/12)
- [July 2022 (1)](https://blog.cmecorp.com/archive/2022/07)
- [October 2022 (1)](https://blog.cmecorp.com/archive/2022/10)
- [December 2022 (1)](https://blog.cmecorp.com/archive/2022/12)

See all

#### About CME Corp.

- [Our Company](https://www.cmecorp.com/about/our-company.html)
- [Careers](https://www.cmecorp.com/about/careers.html)
-  
-  

#### Resources

- [CME Insider's Blog](https://blog.cmecorp.com/)
- [Case Studies](https://www.cmecorp.com/about/case-studies.html)
- [Newsroom](https://blog.cmecorp.com/press-releases)
- [Literature Resources](https://resources.cmecorp.com/)

#### Quick Links

- [Find Products](https://www.cmecorp.com/shop)
- [Privacy Policy](https://www.cmecorp.com/privacy-policy-cookie-restriction-mode)
- [Sales, Shipping & Return Policies](https://www.cmecorp.com/sales-shipping)
- [Credit Application](https://www.cmecorp.com/about/credit-application.html)

[![](https://www.cmecorp.com/media/public/linked_in_blog.png)](https://www.linkedin.com/company/cme-medical/) [![](https://www.cmecorp.com/media/public/facebook_blog.png)](https://www.facebook.com/cmecorp/) [![](https://www.cmecorp.com/media/public/instagram_blog.png)](https://www.instagram.com/cme_corp/)

© 2026 CME Corp - An ESOP Company  
Delivering a Better Experience